-Innovative CHROMA stent platform with cobalt chromium alloy
-Strut thickness only 84um
-Classic rapamycin
-Optimized drug dosage
-Potential faster healing process without affecting restenosis rate
-Unique formulated biodegradable polylactic acid(PLA) coating as drug carrier, which will degrade completely into CO2&H2O in 6-9 month with reduced chronic inflammatory reactions
-Effective reduction of the risk of in-stent ST/VLST
-Targeted drug release via abluminal biodegradable coating
-Larger side branch access with better operation experience
-More complete specifications and sizes give clinicians more better selections